期刊
JOURNAL OF INORGANIC BIOCHEMISTRY
卷 102, 期 2, 页码 347-358出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jinorgbio.2007.09.008
关键词
Ru(III) complexes; anticancer drug; dpq
A novel Ru(III) complex, mer-[RuCl3(CH3CN)(dpq)] (1), has been synthesized and characterized by X-ray diffraction, where dpq = dipyrido[3,2-d:2',3'-f]quinoxaline. Its chemical and biological properties have been intensively compared with those of mer-[RuCl3(DMSO)(dpq)] (DMSO = dimethyl sulfoxide) (2). It has been found that the stability in buffered solutions and the reduction potential for the Ru-III/Ru-II couple can be modulated by changing the small molecule bonded to the Ru(III) center. Interactions of 1 with DNA have been investigated by DNA melting experiments, DNA competitive binding with EB (ethidium bromide), plasmid DNA cleavage experiments and viscosity measurements. The interaction of 1 and 2 with BSA (bovine serum albumin) has also been studied using fluorescent quenching method. The experimental results show that 1 exerts higher affinity towards DNA and BSA than 2 does. The cytotoxicity of 1 has been evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method, and 2 shows slightly higher anticancer potency than 1 does against all the cell lines screened. Attempts are made to clarify the possible antitumor mechanisms of these two complexes by analyzing the experimental results presented. (c) 2007 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据